Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 15Prostatic Neoplasms 9Colorectal Neoplasms 7Ovarian Neoplasms 5Endometrial Neoplasms 5Colonic Neoplasms 5Rectal Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 4Pancreatic Neoplasms 3Leukemia, Myeloid, Acute 3Brain Neoplasms 3Wilms Tumor 2Urogenital Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplastic Syndromes, Hereditary 2Neoplasms, Unknown Primary 2Neoplasm Metastasis 2Melanoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Leukemia 2Kidney Neoplasms 2Hereditary Breast and Ovarian Cancer Syndrome 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Glioma 2

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Specimen Handling 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Biopsy 5trametinib 3fludarabine 3dabrafenib 3Tacrolimus 3Melphalan 3Cyclophosphamide 3Busulfan 3ulixertinib 2tipifarnib 2thymoglobulin 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2fludarabine phosphate 2erdafitinib 2ensartinib 2Whole-Body Irradiation 2Vemurafenib 2Rituximab 2Mycophenolic Acid 2LY3023414 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Histiocytosis, Langerhans-Cell × Genetic Testing × Clear all
NCT05028621 2026-05-07

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Case Comprehensive Cancer Center

Phase NA Suspended
135 enrolled
LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡